Literature DB >> 21300904

Low-resolution structure of a vesicle disrupting α-synuclein oligomer that accumulates during fibrillation.

Lise Giehm1, Dmitri I Svergun, Daniel E Otzen, Bente Vestergaard.   

Abstract

One of the major hallmarks of Parkinson disease is aggregation of the protein α-synuclein (αSN). Aggregate cytotoxicity has been linked to an oligomeric species formed at early stages in the aggregation process. Here we follow the fibrillation process of αSN in solution over time using small angle X-ray scattering and resolve four major coexisting species in the fibrillation process, namely monomer, dimer, fibril and an oligomer. By ab initio modeling to fit the data, we obtain a low-resolution structure of a symmetrical and slender αSN fibril in solution, consisting of a repeating unit with a maximal distance of 900 Å and a diameter of ∼180 Å. The same approach shows the oligomer to be shaped like a wreath, with a central channel and with dimensions corresponding to the width of the fibril. The structure, accumulation and decay of this oligomer is consistent with an on-pathway role for the oligomer in the fibrillation process. We propose an oligomer-driven αSN fibril formation mechanism, where the fibril is built from the oligomers. The wreath-shaped structure of the oligomer highlights its potential cytotoxicity by simple membrane permeabilization. This is confirmed by the ability of the purified oligomer to disrupt liposomes. Our results provide the first structural description in solution of a potentially cytotoxic oligomer, which accumulates during the fibrillation of αSN.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21300904      PMCID: PMC3044375          DOI: 10.1073/pnas.1013225108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  A general model for amyloid fibril assembly based on morphological studies using atomic force microscopy.

Authors:  Ritu Khurana; Cristian Ionescu-Zanetti; Maighdlin Pope; Jie Li; Liza Nielson; Marina Ramírez-Alvarado; Lynn Regan; Anthony L Fink; Sue A Carter
Journal:  Biophys J       Date:  2003-08       Impact factor: 4.033

2.  Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy.

Authors:  K A Conway; S J Lee; J C Rochet; T T Ding; R E Williamson; P T Lansbury
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

3.  Heparin and other glycosaminoglycans stimulate the formation of amyloid fibrils from alpha-synuclein in vitro.

Authors:  Jeffrey A Cohlberg; Jie Li; Vladimir N Uversky; Anthony L Fink
Journal:  Biochemistry       Date:  2002-02-05       Impact factor: 3.162

4.  Vesicle permeabilization by protofibrillar alpha-synuclein: implications for the pathogenesis and treatment of Parkinson's disease.

Authors:  M J Volles; S J Lee; J C Rochet; M D Shtilerman; T T Ding; J C Kessler; P T Lansbury
Journal:  Biochemistry       Date:  2001-07-03       Impact factor: 3.162

5.  Vesicle permeabilization by protofibrillar alpha-synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism.

Authors:  Michael J Volles; Peter T Lansbury
Journal:  Biochemistry       Date:  2002-04-09       Impact factor: 3.162

6.  The structure of dopamine induced alpha-synuclein oligomers.

Authors:  Agata Rekas; Robert B Knott; Anna Sokolova; Kevin J Barnham; Keyla A Perez; Colin L Masters; Simon C Drew; Roberto Cappai; Cyril C Curtain; Chi L L Pham
Journal:  Eur Biophys J       Date:  2010-03-23       Impact factor: 1.733

7.  Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct.

Authors:  K A Conway; J C Rochet; R M Bieganski; P T Lansbury
Journal:  Science       Date:  2001-11-09       Impact factor: 47.728

8.  Neurodegenerative disease: amyloid pores from pathogenic mutations.

Authors:  Hilal A Lashuel; Dean Hartley; Benjamin M Petre; Thomas Walz; Peter T Lansbury
Journal:  Nature       Date:  2002-07-18       Impact factor: 49.962

Review 9.  Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson's disease.

Authors:  Michael J Volles; Peter T Lansbury
Journal:  Biochemistry       Date:  2003-07-08       Impact factor: 3.162

10.  Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils.

Authors:  Hilal A Lashuel; Benjamin M Petre; Joseph Wall; Martha Simon; Richard J Nowak; Thomas Walz; Peter T Lansbury
Journal:  J Mol Biol       Date:  2002-10-04       Impact factor: 5.469

View more
  76 in total

1.  α-Synuclein oligomers pump it up!

Authors:  Philipp J Kahle; Naoto Sugeno; Angelos Skodras
Journal:  EMBO J       Date:  2015-09-15       Impact factor: 11.598

Review 2.  The role of lipids in α-synuclein misfolding and neurotoxicity.

Authors:  Cathryn L Ugalde; Victoria A Lawson; David I Finkelstein; Andrew F Hill
Journal:  J Biol Chem       Date:  2019-05-07       Impact factor: 5.157

Review 3.  Biophysics of α-synuclein membrane interactions.

Authors:  Candace M Pfefferkorn; Zhiping Jiang; Jennifer C Lee
Journal:  Biochim Biophys Acta       Date:  2011-07-28

4.  MOAG-4 promotes the aggregation of α-synuclein by competing with self-protective electrostatic interactions.

Authors:  Yuichi Yoshimura; Mats A Holmberg; Predrag Kukic; Camilla B Andersen; Alejandro Mata-Cabana; S Fabio Falsone; Michele Vendruscolo; Ellen A A Nollen; Frans A A Mulder
Journal:  J Biol Chem       Date:  2017-03-23       Impact factor: 5.157

5.  Coexistence of ribbon and helical fibrils originating from hIAPP(20-29) revealed by quantitative nanomechanical atomic force microscopy.

Authors:  Shuai Zhang; Maria Andreasen; Jakob T Nielsen; Lei Liu; Erik H Nielsen; Jie Song; Gang Ji; Fei Sun; Troels Skrydstrup; Flemming Besenbacher; Niels C Nielsen; Daniel E Otzen; Mingdong Dong
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-06       Impact factor: 11.205

6.  Fibrillar α-synuclein and huntingtin exon 1 assemblies are toxic to the cells.

Authors:  Laura Pieri; Karine Madiona; Luc Bousset; Ronald Melki
Journal:  Biophys J       Date:  2012-06-19       Impact factor: 4.033

7.  Number and Brightness analysis of alpha-synuclein oligomerization and the associated mitochondrial morphology alterations in live cells.

Authors:  N Plotegher; E Gratton; L Bubacco
Journal:  Biochim Biophys Acta       Date:  2014-02-20

Review 8.  Implications of peptide assemblies in amyloid diseases.

Authors:  Pu Chun Ke; Marc-Antonie Sani; Feng Ding; Aleksandr Kakinen; Ibrahim Javed; Frances Separovic; Thomas P Davis; Raffaele Mezzenga
Journal:  Chem Soc Rev       Date:  2017-10-30       Impact factor: 54.564

Review 9.  Interplay between α-synuclein amyloid formation and membrane structure.

Authors:  Emma I O'Leary; Jennifer C Lee
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2018-10-02       Impact factor: 3.036

10.  Alpha-Synuclein Fibrils Interact with Dopamine Reducing its Cytotoxicity on PC12 Cells.

Authors:  Masoome Khalife; Dina Morshedi; Farhang Aliakbari; Amir Tayaranian Marvian; Hossein Mohammad Beigi; Sadegh Azimzadeh Jamalkandi; Francisco Pan-Montojo
Journal:  Protein J       Date:  2015-08       Impact factor: 2.371

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.